S K Carter, M Slavik. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Acrylates/therapeutic useAlkylating Agents/therapeutic useAncitabine/therapeutic useAnimalsAntibiotics, Antineoplastic/therapeutic useAntimetabolites, Antineoplastic/therapeutic useAntineoplastic Agents/therapeutic useAzacitidine/therapeutic useChemical PhenomenaChemistryChromomycins/therapeutic useCisplatin/therapeutic useDNA, Neoplasm/metabolismDrug Evaluation, PreclinicalEtoposide/therapeutic useHumansIfosfamide/therapeutic useLeukemia L1210/drug therapyMiceMitosis/drug effectsNational Institutes of Health (U.S.)Neoplasms/drug therapyNeoplasms, Experimental/drug therapyRazoxane/therapeutic useTegafur/therapeutic useTeniposide/therapeutic useUnited States
Substances： See more » AcrylatesAlkylating AgentsAntibiotics, AntineoplasticAntimetabolites, AntineoplasticAntineoplastic AgentsChromomycinsDNA, NeoplasmTegafurRazoxaneEtoposideTeniposideAncitabineAzacitidineCisplatinIfosfamide
Year: 1976 PMID： 62615 DOI： 10.1016/s0305-7372(76)80016-3
Source DB: PubMed Journal: Cancer Treat Rev ISSN： 0305-7372 Impact factor: 12.111